Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Kala Pharmaceuticals

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers

Benzinga · Nov 9, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga · May 25, 2022

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga · May 24, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Kala Pharmaceuticals Shares Are Rising Today

Kala Pharmaceuticals Inc (NASDAQ: KALA) shares are trading higher after the company said it would sell its EYSUVIS and INVELTYS treatments for $60 million.

Benzinga · May 23, 2022

Earnings Preview For Kala Pharmaceuticals

Kala Pharmaceuticals (NASDAQ:KALA) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Kala Pharmaceuticals will report an earnings per share (EPS) of $-0.36.

Benzinga · May 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022

Upgrades

Benzinga · Mar 30, 2022

Kala Pharmaceuticals's Return On Capital Employed Insights

Benzinga Pro data, Kala Pharmaceuticals (NASDAQ:KALA) reported Q4 sales of $1.86 million. Earnings fell to a loss of $47.57 million, resulting in a 69.12% decrease from last quarter.

Benzinga · Mar 30, 2022

Read news from The Economist, FT, and more,
with one subscription

Recap: Kala Pharmaceuticals Q4 Earnings

Kala Pharmaceuticals (NASDAQ:KALA) reported its Q4 earnings results on Tuesday, March 29, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga · Mar 29, 2022

Earnings Outlook For Kala Pharmaceuticals

Kala Pharmaceuticals (NASDAQ:KALA) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that Kala Pharmaceuticals will report an earnings per share (EPS) of $-0.41.

Benzinga · Mar 28, 2022

How To Attend Kala Pharmaceuticals Q4 2021 Earnings Conference Call

Kala Pharmaceuticals (NASDAQ:KALA) will host a conference call at 08:00 AM ET on March 29, 2022, to discuss Q4 2021 earnings results. How to Attend Kala Pharmaceuticals (KALA) Conference Call Follow this link to access the live webcast.

Benzinga · Mar 24, 2022

Coverage From

Benzinga

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.